Parabilis Medicines, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Parabilis Medicines, Inc. (PBLS) reported Net Income (Loss) Available to Common Stockholders, Basic of -$66.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-13
- Parabilis Medicines, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$66.95M.
- Parabilis Medicines, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was -$44.99M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month |
|---|---|---|
| 2026-06-30 | -$66.95M 10-Q · filed 2026-08-13 | -$137.84M 10-Q · filed 2026-08-13 |
| 2025-06-30 | -$44.99M 10-Q · filed 2026-08-13 | -$93.10M 10-Q · filed 2026-08-13 |